Home Blog Page 813

CNOOC Limited Announces Huang Yongzhang as Chief Executive Officer

HONG KONG, March 20, 2026 /PRNewswire/ — CNOOC Limited (the “Company”, SEHK: 00883 (HKD Counter) and 80883 (RMB Counter), SSE: 600938) announces today that Mr. Huang Yongzhang has been appointed as the Vice Chairman, an Executive Director, the Chief Executive Officer, the President and a member of the Strategy and Sustainability Committee.

The biographical details of Mr. Huang Yongzhang are set out below:   

Born in 1966, Mr. Huang is a professor-level senior engineer with a Doctor of Science degree. Mr. Huang previously served as Vice President of CNPC International (Nile) Ltd., Vice President and Chief Safety Officer of China Oil Exploration and Development Corporation, Executive Vice President and President of CNPC Middle East Corporation, and Director of CNPC Middle East Regional Coordination Committee. From April 2020 to September 2025, Mr. Huang served as Vice President of China National Petroleum Corporation during which he concurrently served as the Chief Safety Officer. From September 2020 to September 2025, Mr. Huang served as a Director of PetroChina Company Limited, during which he concurrently served as the President from March 2021. Mr. Huang has served as a Director and the General Manager of China National Offshore Oil Corporation since September 2025.

— End —

Notes to Editors:

More information about the Company is available at https://www.cnoocltd.com.

*** *** *** ***

This press release includes forward looking information, including statements regarding the likely future developments in the business of the Company and its subsidiaries, such as expected future events, business prospects or financial results. The words “expect”, “anticipate”, “continue”, “estimate”, “objective”, “ongoing”, “may”, “will”, “project”, “should”, “believe”, “plans”, “intends” and similar expressions are intended to identify such forward-looking statements. These statements are based on assumptions and analyses made by the Company as of this date in light of its experience and its perception of historical trends, current conditions and expected future developments, as well as other factors that the Company currently believes are appropriate under the circumstances. However, whether actual results and developments will meet the current expectations and predictions of the Company is uncertain. Actual results, performance and financial condition may differ materially from the Company’s expectations, including but not limited to those associated with macro-political and economic factors, fluctuations in crude oil and natural gas prices, the highly competitive nature of the oil and natural gas industry, climate change and environmental policies, the Company’s price forecast, mergers, acquisitions and divestments activities, HSSE and insurance policies and changes in anti-corruption, anti-fraud, anti-money laundering and corporate governance laws and regulations.

Consequently, all of the forward-looking statements made in this press release are qualified by these cautionary statements. The Company cannot assure that the results or developments anticipated will be realised or, even if substantially realised, that they will have the expected effect on the Company, its business or operations.

*** *** *** ***

*** *** *** ***

For further enquiries, please contact:

Liu Cui
Media & Public Relations
CNOOC Limited
Tel: +86-10-8452-6641
Fax: +86-10-8452-1441
E-mail: mr@cnooc.com.cn

Cheng Yao
Ever Bloom (HK) Communications Consultants Group Limited
Tel: +852 5540 0725
Fax: +852 2111 1103
E-mail:cnooc.hk.list@everbloom.com.cn

 

Yunji to Report Second Half and Fiscal Year 2025 Financial Results on March 27, 2026

HANGZHOU, China, March 20, 2026 /PRNewswire/ — Yunji Inc. (“Yunji” or the “Company”) (NASDAQ: YJ), a leading membership-based social e-commerce platform, today announced that it plans to release its unaudited financial results for the second half and fiscal year ended December 31, 2025, before the market opens on Friday, March 27, 2026. The earnings release will be available on the Company’s investor relations website at https://investor.yunjiglobal.com/.

The Company will hold a conference call on Friday, March 27, 2026 at 7:30 A.M. Eastern Time or 7:30 P.M. Beijing/Hong Kong Time to discuss its earnings. Listeners may access the call by dialing the following numbers:

International:

1-412-902-4272

United States Toll Free:

1-888-346-8982

Mainland China Toll Free:   

4001-201203

Hong Kong Toll Free:      

800-905945

Conference ID:  

Yunji Inc.

The replay will be accessible through April 03, 2026 by dialing the following numbers:

United States Toll Free:

1-855-669-9658

International:

1-412-317-0088

Replay Access Code:

4499274

A live and archived webcast of the conference call will also be available at the Company’s investor relations website at https://investor.yunjiglobal.com/.

About Yunji Inc.

Yunji Inc. is a leading social e-commerce platform in China that has pioneered a unique, membership-based model to leverage the power of social interactions. The Company’s e-commerce platform offers high-quality products at attractive prices across a wide variety of categories catering to the day-to-day needs of Chinese consumers. In addition, the Company uses advanced technologies including big data and artificial intelligence to optimize user experience and incentivize members to promote the platform as well as share products with their social contacts. Through deliberate product curation, centralized merchandise sourcing, and efficient supply chain management, Yunji has established itself as a trustworthy e-commerce platform with high-quality products and exclusive membership benefits, including discounted prices.

For more information, please visit https://investor.yunjiglobal.com/

Investor Relations Contact

Yunji Inc.
Investor Relations
Email: Yunji.IR@icrinc.com
Phone: +1 (646) 224-6957

ICR, LLC
Robin Yang
Email: Yunji.IR@icrinc.com
Phone: +1 (646) 224-6957

Earendil Labs Announces $787 Million in Financing to Scale AI-Driven Biologics Discovery and Development

WILMINGTON, Del., March 20, 2026 /PRNewswire/ — Earendil Labs, an AI-driven biotechnology company advancing next-generation biologics, today announced that it has raised $787 million in financing rounds. The investment included participation by a group of leading global investors, including Dimension Capital, DST Global, INCE Capital, Luminous Ventures, Miracle Capital, Sanofi, and Biotech Development Fund (created by Hillhouse and Pfizer), alongside other existing and new technology and healthcare-focused investors.

The funding will accelerate Earendil Labs’ AI-driven R&D platform, expand its interdisciplinary teams, and advance a growing pipeline of antibody and biologics programs, with the goal of delivering first-in-class and best-in-class therapies for patients with serious diseases.

“AI is at the core of everything we do — not as a research tool, but as a production engine for real therapeutic programs,” said Jian Peng, PhD, Founder and CEO of Earendil Labs. “This financing allows us to operate at a fundamentally different scale, advancing multiple programs toward the clinic while building an R&D organization designed for long-term impact.”

Earendil Labs integrates artificial intelligence across the full life cycle of biologics R&D, enabling the systematic generation and progression of differentiated therapeutic programs. The company’s AI-native platform has produced more than 40 programs, including HXN-1001, a half-life extended anti-TL1A antibody which is ready for Phase 2 clinical development, together with multiple IND submissions planned in 2026 and 2027.

“Our focus is ultimately on patients suffering from diseases that still lack effective treatment options,” said Zhenping Zhu, MD, PhD, Co-Founder, President and Co-CEO of Earendil Labs. “This funding greatly strengthens our ability to translate AI-enabled innovation into potentially transformative medicines and provides opportunities to partner with global leaders to accelerate our research and development programs worldwide. “

The platform’s productivity and R&D execution are further validated through strategic collaborations with Sanofi. In 2025, Earendil Labs announced a worldwide exclusive license agreement with Sanofi for next-generation bispecific antibodies for autoimmune and inflammatory bowel diseases, covering HXN-1002 and HXN-1003. More recently, Earendil Labs and Sanofi entered a broader strategic collaboration to apply its AI-driven discovery platform to multiple autoimmune and inflammatory disease programs.

“Earendil Labs stands out for its ability to translate AI innovation into real, scalable R&D execution,” said Zavain Dar, Founding Managing Partner at Dimension Capital. “The team has shown that AI can consistently generate high-quality biologics programs and advance them toward the clinic. We are excited to support Earendil Labs as it builds a new paradigm for biologics discovery and development.”

With this funding, Earendil Labs plans to scale its AI-driven research and development across biologics discovery and development while expanding its scientific, engineering, and translational teams to support pipeline growth. The capital will also advance multiple internal programs toward clinical milestones and deepen strategic partnerships to accelerate the delivery of innovative biologics to patients globally.

About Earendil Labs Earendil Labs is an AI-powered biotechnology company advancing next-generation biologics for patients with autoimmune diseases, cancer, and other areas of significant unmet medical need. By integrating artificial intelligence across the full R&D life cycle, Earendil Labs and its affiliate Helixon Therapeutics have been building a scalable engine to systematically generate and advance high-quality therapeutic programs.

The company’s AI-native approach enables efficient creation, optimization, and progression of protein-based biologics with the potential to be first-in-class and best-in-class, translating computational innovation into real clinical and patient impact. Through a combination of internal pipeline development and strategic partnerships, Earendil Labs aims to deliver transformative medicines to patients worldwide.

 

Eason Technology announces election of new director

HONG KONG, March 20, 2026 /PRNewswire/ — Eason Technology Limited (“Eason” or the “Company”) (NYSE American: DXF), today announced that Haitao He has been elected to the board of directors, and concurrently serves as the head of the healthcare business team.

Haitao is an accomplished serial entrepreneur. He has participated in the founding and successful establishment of multiple healthcare enterprises, and concurrently serves as the CEO of a healthcare investment company.

Eason’s CEO Stanley commented, “I would like to welcome Haitao as a valuable addition to the Eason board. Haotao’s experience, perspectives and strategic insights are a great fit for Eason Tech. The Company’s management has full confidence in expanding its real estate operations and digital technology businesses into the application scenarios of the healthcare industry.”

About Eason Technology Limited

Eason Technology Limited is a company engaged in real estate operation management and investment and digital technology security business in Hong Kong, China.

Safe Harbor Statement

Certain statements made in this release are “forward looking statements” within the meaning of the “safe harbor” provisions of the United States Private Securities Litigation Reform Act of 1995. When used in this press release, the words “estimates,” “projected,” “expects,” “anticipates,” “forecasts,” “plans,” “intends,” “believes,” “seeks,” “may,” “will,” “should,” “future,” “propose” and variations of these words or similar expressions (or the negative versions of such words or expressions) are intended to identify forward-looking statements. These forward-looking statements are not guarantees of future performance, conditions or results, and involve a number of known and unknown risks, uncertainties, assumptions and other important factors, many of which are outside the Company’s control, that could cause actual results or outcomes to differ materially from those discussed in the forward-looking statements. Important factors, among others, are the ability to manage growth; ability to identify and integrate other future acquisitions; ability to obtain additional financing in the future to fund capital expenditures; fluctuations in general economic and business conditions; costs or other factors adversely affecting our profitability; litigation involving patents, intellectual property, and other matters; potential changes in the legislative and regulatory environment; a pandemic or epidemic. The forward-looking statements contained in this release are also subject to other risks and uncertainties, including those more fully described in the Company’s filings with the Securities and Exchange Commission, which are available for review at www.sec.gov. The Company undertakes no obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as required by applicable law. Such information speaks only as of the date of this release.

HKSH Cancer Centre’s Precision Targeting Technologies Leading the Evolution of “Hypofractionation”

Asia’s First Study: 5 Sessions of Proton Therapy to Control Early-Stage Prostate Cancer

HONG KONG, March 20, 2026 /PRNewswire/ — HKSH Medical Group (HKSH) today announced the results of Asia’s first clinical study on early-stage prostate cancer patients receiving five-session of proton therapy.* The results show significant efficacy, with a marked decline in prostate-specific antigen (PSA) levels and only mild side effects. Proton therapy for prostate cancer generally requires about 30 treatment sessions over 8 to 9 weeks. Since the launch of proton therapy service in 2023, HKSH Cancer Centre has advanced the precision of treatment to achieve “hypofractionation”, drastically reducing the number of treatment session by 80%. For early-stage prostate cancer, there is an option of 5 sessions of proton therapy within 2 to 3 weeks to achieve disease control. The unique physical properties of proton beam can precisely target the tumour with minimal damage to nearby vital organs such as the bladder and bowel, thereby helping to enhance patients’ quality of life throughout their cancer journey.

(From left) Dr. Ben YU, Head of Medical Physics Department of HKSH, Dr. Joseph CHAN, Chief Medical Officer, HKSH Medical Group and Deputy Medical Superintendent, Hong Kong Sanatorium & Hospital, Mr. Wyman LI, Chief Operating Officer, HKSH Medical Group and Director, Hong Kong Sanatorium & Hospital, Dr. Darren POON, Associate Director, HKSH Comprehensive Oncology Centre announced the data from Asia’s first MRI-guided five-session proton therapy study for early-stage prostate cancer patients.
(From left) Dr. Ben YU, Head of Medical Physics Department of HKSH, Dr. Joseph CHAN, Chief Medical Officer, HKSH Medical Group and Deputy Medical Superintendent, Hong Kong Sanatorium & Hospital, Mr. Wyman LI, Chief Operating Officer, HKSH Medical Group and Director, Hong Kong Sanatorium & Hospital, Dr. Darren POON, Associate Director, HKSH Comprehensive Oncology Centre announced the data from Asia’s first MRI-guided five-session proton therapy study for early-stage prostate cancer patients.

Mr. Wyman LI, Chief Operating Officer of HKSH Medical Group and Director of Hong Kong Sanatorium & Hospital, remarked, “The integration of proton therapy and targeting technologies is the cornerstone to the successful implementation of ‘hypofractionation‘. This achievement also reflects HKSH’s ongoing commitment to advancing clinical application, enabling cancer patients to benefit from even more advanced precision treatments with less side effects. Taking a further leap forward, the HKSH research team is now exploring the feasibility of further reducing treatment of early-stage prostate cancer using proton therapy from 5 to 2 sessions. HKSH has also introduced the world’s first Photon-Counting CT Simulation System (PCCT-Sim) with advanced simulation capabilities which can be applied in prostate cancer proton therapy planning for even more effective disease control.”

Asia’s First Study: Five Sessions of Proton Therapy to Target Prostate Tumours

Prostate cancer predominantly affects older adults, but risk does not simply rise with age, the incidence is highest among those aged 65–74.  Local data in 2023 shows that new cases in this age group account for about half of all diagnoses, underscoring the urgent need for more effective cancer management strategies. To assess the clinical efficacy of five-session proton therapy, HKSH commenced a clinical study to analyse the data of 94 early-stage prostate cancer patients who received Stereotactic Body Proton Therapy between June 2024 and January 2026. The report covers a median follow-up of 10.93 months (range: 0.9 to 25.5 months). After five sessions of proton therapy, the patients’ PSA levels dropped sharply from a baseline of 12.57 ng/mL (±13.59 ng/mL) to 1.13 ng/mL (±2.07 ng/mL) three months post-treatment, maintaining high efficacy despite fewer treatment sessions.

Dr. Darren POON, Associate Director of HKSH Comprehensive Oncology Centre and Specialist in Clinical Oncology, who led this study explained that due to the high concentration of proton beams and precise delivery to the target area striking the tumour, the majority of patients in the study did not experience adverse reactions of Grade ≥2 toxicities after treatment. Patient-Reported Outcome Measures (PROMs) indicated favorable urinary and bowel function scores three months post-treatment, suggesting minimal impact on quality of life. The most common adverse reactions were related to the urinary system. During the acute phase, 33.0% (31/94) of patients experienced relatively mild Grade 1 dysuria i.e. having difficulty in urination, which subsequently improved. This study is still ongoing to gather long-term follow-up data. As Asia’s first study on magnetic resonance imaging-guided five-session proton therapy, it further establishes HKSH’s leading position in the field of proton therapy within the region and provides an important foundation for developing more precise and safer treatment options across Asia in the future.

Hypofractionation: Precision Planning and Targeting

Dr. POON pointed out that the core technologies behind “hypofractionation”: “For every case and treatment, our proton therapy team would utilise Intensity Modulated Proton Therapy (IMPT) with pencil-beam scanning. Before treatment, the tumour’s shape and size are delineated, and the radiation intensity of each beam at different positions within the tumour is precisely calculated. Patients would also undergo MRI and CT scans before treatment, which are cross-referenced with the proton therapy system’s real-time X-ray imaging to ensure accurate targeting.” To further protect nearby organs, doctors may use rectal spacers to increase rectum-prostate distance. Bladder volume scans are also performed to assess bladder filling before each treatment session, aiding in accurate tumour targeting to minimise unnecessary radiation exposure.

Hypofractionation: Overcoming Tumour Movement, Minimising Side Effects

Proton beam accurately targeting the tumour according to treatment plan can greatly reduce side effects. However, prostate tumours may shift slightly due to soft-tissue movement. Even though these movements are slight, HKSH strives to minimise any deviation to the smallest possible range, further reducing the risk of side effects. Multiple techniques are applied clinically, including implanting fiducial markers within the prostate to track the tumour’s position real-time, ensuring precise radiation delivery to the tumour.

The number of treatment sessions and potential side effects are primary factors for cancer patients when considering radiotherapy. The promising clinical results of HKSH’s five-session proton therapy provide strong reassurance to patients, allowing greater flexibility for personalised treatment plans. Building on this, HKSH has already commenced a clinical study on two-session proton therapy. This study will enroll 35 patients with histologically diagnosed low-to-intermediate risk localised prostate cancer and will follow them for five years. The aim is to investigate both the short-term and long-term safety and efficacy of the treatment. These findings will help doctors and patients make more informed decisions about “hypofractionation”.

HKSH firmly believes that talent and technology are equally important. HKSH collaborated with the National Cancer Centre to organise the ‘Proton Therapy Joint Training Course’ in June 2025 and subsequently commenced the 10-month ‘HKSH Cancer Centre Proton Therapy Training Programme’. In November 2025, HKSH hosted the Annual Conference of the Asia-Oceania Particle Therapy Co-operative Group (PTCOG-AO) as a platform to integrate clinical expertise with a global perspective. HKSH aims to establish a premier platform for continuous learning and advancement in the Asia-Pacific region, elevating the overall standard of proton therapy to benefit more patients.

Patient Sharing – Mr. Li

Mr. Li, a 69-year-old retired teacher, discovered elevated PSA levels (>12 ng/mL) and an enlarged prostate during a routine checkup in December 2024, despite no symptoms. The checkup also revealed coronary artery blockage, requiring an angioplasty procedure and anticoagulant medication in March 2025, delaying prostate cancer treatment. In September 2025, Mr. Li underwent a biopsy at a public hospital and was diagnosed with early-stage prostate cancer with no metastasis. As Mr. Li and his family preferred to avoid surgery, the public hospital considered conventional radiotherapy more suitable for Mr. Li’s overall health condition than the shorter-course stereotactic body photon radiotherapy, and advised him to undergo 20 sessions of treatment.

Although his PSA had risen to over 14 ng/mL by then, Mr. Li and his family were concerned about the relatively long course of conventional radiotherapy and its potential side effects. After learning more about proton therapy with minimal impact on surrounding vital organs and the prospect of controlling the tumour with just five sessions, he decided to proceed with proton therapy and commenced his 2.5-week course of treatment in December 2025. Mr. Li shared that he experienced almost no discomfort during or after the treatment, with just some markings on his hip, describing it as “feel like haven’t undergone any treatment at all”. His PSA level has also dropped significantly. Mr. Li is grateful for the opportunity to receive proton therapy as he can now continue to enjoy jogging and travelling with his wife, spending quality time with his grandchildren.

*Stereotactic Body Proton Therapy (SBPT) for Localized Prostate Cancer: Preliminary Clinical Results of Clinician- and Patient-Reported Outcomes [source – PTCOG-AO 2025]

# Please email to RCH-StudyInquiry@hksh-hospital.com for more information about HKSH’s proton therapy clinical study. 

About HKSH Medical Group

Officially launched in September 2017, HKSH Medical Group promotes public health and advanced medicine through a multi-faceted, coordinated approach across clinical services, medical education, scientific research and public health education. Members of the Group, including Hong Kong Sanatorium & Hospital, HKSH Healthcare, HKSH Eastern Medical Centre, HKSH Cancer Centre and HKSH Institute for Innovation & Professional Development, are dedicated to offering top-quality holistic care to patients.

Established in 1922, Hong Kong Sanatorium & Hospital is one of the key members of HKSH Medical Group and a leading private hospital in Hong Kong. Living up to its motto of ‘Quality in Service, Excellence in Care’, the Hospital is committed to serving the public as well as promoting medical education and research.

For more information about HKSH Medical Group, please visit http://www.hksh.com.

Skyrover Debuts at Best Buy, Delivering Premium Drones with Strong Value for U.S. Creators

DOVER, Del., March 20, 2026 /PRNewswire/ — Skyrover, a next-generation consumer drone brand focused on the U.S. market, today announced its official launch through Best Buy, one of America’s most trusted electronics retailers. The launch coincides with Best Buy’s Spring Sale starting March 23, offering up to 33% off select Skyrover models.

SKYROVER NOW AT BEST BUY
SKYROVER NOW AT BEST BUY

“Being selected by Best Buy is a strong endorsement of Skyrover’s quality, reliability, and value,” said Henry Zhang, Founder of Skyrover. “Skyrover was designed specifically for American creators. FCC-approved, worry removed, our drones provide a safe, high-performance flight experience tailored to U.S. users. We leverage a world-class supply chain to ensure rapid iteration, premium quality, and fast response to feedback.”

A Drone for the Everyday Creator

Skyrover drones are built to be more than just high-spec devices—they are creative partners helping users capture life’s extraordinary moments. From family activities to travel adventures and content creation, Skyrover empowers users to tell their stories in real-time with intuitive controls, seamless software, and stable flight performance.

Independent Brand, U.S.-Based Support

Skyrover operates independently while collaborating with a highly responsive, premium supply chain. Local support, swap not mend, ensures fast, reliable service for American customers. With top retailers supplying Skyrover, the drones are easy to find, purchase, and experience firsthand. “Our goal is to deliver a distinctly American user experience with global-grade quality and reliability,” said [Nathan Chan] Product Head of Skyrover.

Exceptional Value

Skyrover delivers premium drone experiences with high-end features and reliable performance, without the traditional premium markup, offering exceptional value for American creators.

Availability and Spring Promotion

Skyrover drones will be available in select Best Buy stores both online and offline. Early adopters can take advantage of Spring Sale discounts of up to 33%, as well as in-store demo experiences.

Online purchase links for early access:

Skyrover X1 Fly More Combo: https://www.bestbuy.com/product/skyrover-x1-fly-more-combo-8k-drone-with-remote-controller-gray/J3R856JJTJ

Skyrover S1 Fly More Combo: https://www.bestbuy.com/product/skyrover-s1-fly-more-combo-8k-drone-with-remote-controller-white/J3Q5QSQR2C

About Skyrover

Skyrover is a premium consumer drone brand dedicated to U.S. creators. Combining world-class supply chain efficiency with U.S.-based support, FCC-approved reliability, and accessible pricing, Skyrover empowers users to capture, share, and elevate everyday moments with precision, reliability, and style. www.skyroverdrone.com

 

MarketingPulse and eTailingPulse attract more than 1,700 industry professionals

Global e-commerce and brand experts explore growth opportunities

HONG KONG, March 20, 2026 /PRNewswire/ — Organised by the Hong Kong Trade Development Council (HKTDC), MarketingPulse and eTailingPulse successfully concluded at the Hong Kong Convention and Exhibition Centre (HKCEC). The premier annual e-commerce and brand marketing events drew a vibrant crowd of more than 1,700 industry professionals from 22 countries and regions, who gathered in Hong Kong to navigate the ever-evolving marketing landscape and redefine the blueprint for business growth.

Driving brand evolution through innovation

Welcoming delegates to the conferences, Sophia Chong, Executive Director of the HKTDC, said: “Rapid advances in digital technologies are allowing e-commerce to reshape the market landscape, transforming how businesses reach consumers, transact and scale. From AI-driven personalisation to social commerce, the pace of change is unprecedented, and with this change comes significant opportunity. The theme for this year’s events, “Generate New Growth“, challenges us to seize these opportunities by exploring how fresh ideas, new technologies and bold strategies can power the next wave of momentum.”

E-commerce experts unpack the latest AI trends

This year’s MarketingPulse and eTailingPulse staged 30 thematic sessions, with a comprehensive agenda exploring topics including “Growth leaders”, “E-commerce new horizons”, “Cutting edge marketing dynamics/new market potential”, ” Social media best practices”, the “Meet the celebrity dialogue series”, and “PR disasters and opportunities”, complemented by a series of digital marketing and e-commerce workshops. More than 85 esteemed e-commerce pioneers, brand leaders, marketing experts and innovative entrepreneurs from around the globe were invited to dissect the latest e-commerce innovations, global marketing trends and consumer opportunities, exploring how to cultivate new growth in a rapidly shifting marketing ecosystem.

When discussing the development and outlook for e-commerce, multiple industry experts at the conferences highlighted the importance of artificial intelligence (AI) applications and its latest trends. Terry Li, Vertical General Manager of Smart Retail, Tencent, noted that “AI is redefining digital commerce, and integrating AI into enterprise architecture properly is key to success. It will not destroy creativity; instead, it can inspire creativity and enable personalised customer experiences.” Bruce Pan, Cross-border Industry Operations Manager of TikTok Shop US, added that the real competitive edge will lie not in generating more content faster, but in combining creative direction, understanding the competitive edges of products and emotional storytelling.

Quick commerce charts a new course for e-commerce

Today’s consumers have an insatiable appetite for convenience and personalisation, compelling brands to accelerate the transformation of their e-marketing strategies. Precision data and AI are fundamentally rewiring consumer experiences. Patrick Zhang, Senior BD Manager of Amazon Global Selling, pointed out that the next phase of globalisation will be defined by how quickly and accurately brands can understand local consumer needs and translate data insights into high-quality growth. Yatong Qiu, Vice President of Taobao & Tmall Group, Alibaba, highlighted how brands and merchants can deploy agile merchandising strategies, real-time digital marketing and speed-oriented approaches to upgrade supply chains and streamline order fulfilment, catering to the modern consumer’s desire for “everything, instantly”. And the “Decoding the Gateway to ASEAN: Cross Border Growth and Market Entry Strategies” session explored tactics for entering the ASEAN market. Speakers including Luca Barni, SVP, Commercial at Lazada Group, shared battle-tested experiences, providing a practical compass for enterprises eyeing ASEAN e-tailing expansion.

Visionary insights from distinguished brand leaders

As the consumer market pivots towards experience-driven models, “taste” and “perception” have become the ultimate battlegrounds for brand competitiveness. Brands are no longer merely delivering product value; they are curating a lifestyle. The “Growth leaders” series at MarketingPulse was inaugurated by Pauline Brown, former Chairman of LVMH North America, who delivered a presentation address on “Aesthetic Intelligence”, illustrating how sensory management and design thinking can elevate brand value and customer experience. “Economic inequality, environmental threats, and the rise of AI make the pursuit of aesthetic intelligence more important than ever,” Ms Brown said. “While AI enhances efficiency, consumers care about brands creating authentic sensory pleasure. Only people can truly convey a clear, well-articulated vision that resonates with customers.”

Haijun Wang, Founder, Chief Executive Officer & Chief Experience Officer of Atour Lifestyle Holdings, shared his philosophy on weaving lifestyle experiences into hotel and lifestyle brand management. By extending the “accommodation experience” into new retail, he demonstrated how to forge brand identity through lifestyle sensibilities and customer resonance. Mr Wang believes that when both service and space strike an emotional chord, the resulting customer loyalty offers an enduring competitive edge. “In the experience economy, emotional value and authentic customer advocacy are becoming more important, making experience not only a point of differentiation, but also a source of sustainable brand growth and long-term development potential,” he said.

As younger generations emerge as the dominant consumer force, the dynamic between brands and youth demographics is being entirely redefined. JinHee Lee, Chief Operating Officer of South Korea’s Olive Young, shared the brand’s triumphant journey from local flagship to a global powerhouse. He showcased how this Korean beauty titan leverages seamless omnichannel operations and data-driven marketing strategies, using technology as a compass to build international competitiveness. “In order for a beauty brand to go global, it’s essential to develop a marketing platform that combines digital promotion and offline data,” he explained. “By integrating physical stores with online apps, we have built a seamless omnichannel ecosystem that continuously adapts to our customers’ lifestyles and needs. providing real time updates on product stock and promotions.”

Crafting an immersive and unforgettable shopping experience to amplify marketing efficacy and fortify long-term brand influence has always been the golden rule for major international brands. Krzysztof Andrzej Kowal, Global Retail Design Director at YSL Beauty, L’Oréal Luxe, took the stage in the session “The Poetics of Branding: Weaving Story, Design, and Emotion into Iconic Narratives”. He shared how to transform physical retail spaces into the ultimate storytelling canvas through the alchemy of “Design × Story × Emotion”. He said that to build emotional connections with customers, “physical stores should transcend showcase roles to become temples of experience and content factories that generate authentic and multi-sensory moments. By blending current trends like Y2K and nostalgia, we build up our persona based on new trends while maintaining our brand culture. At the same time, we maintain a cohesive global identity while adapting to local cultures.”

Creative social content ignites brand resonance

In an era saturated with content and dictated by algorithms, brands and creators must rebuild emotional bridges through authenticity and the power of storytelling. This year’s conferences approached the subject through the lenses of film, television, social media and content creation, exploring how culturally resonant content can captivate audiences and amplify brand value.

Actor and “Threads Admin” Ng Siu-hin joined forces with Kenie Kwok, Creative Strategy Lead at Meta, in the dialogue “Threads for Consumer and Audience Engagement”, comprehensively decoding the “traffic matrix” for the platform. Continuing the creative thread, the “Meet the celebrity dialogue series” invited actor and singer-songwriter Louis Cheung to share his creative odyssey and breakthrough moments. Spanning music to on-screen performances, Louis underscored the importance of staying true to one’s original aspirations and authentic expression, inspiring brands and creators to co-create content with genuine warmth. Meanwhile, content creator and MUSE TV founder Mayao shared his ingenious use of disruptive social media promotional tactics to market music and content, leaving an indelible mark on the public consciousness.

As AI permeates every aspect of the marketing and design sectors, creative thinking faces an unprecedented paradigm shift. Award-winning creative minds, including Stephen Rogers, Group Creative Director at Droga5 from Ireland, explored this dynamic in the session “Creativity & AI: Human vs Artificial Mind“. The speakers revealed that human imagination and intelligent technology are engaged in a symbiotic dance rather than a zero-sum game, with industry pioneers sharing how to masterfully navigate the shifting boundaries between human intuition and AI.

Practical insights and business matchmaking foster cross-sector synergy

Beyond the main forums and InnoTalks series, the events introduced a new feature, “e-Commerce Connect”, that brought together nearly 30 local and international exhibitors to showcase the latest one-stop e-commerce solutions. A series of digital marketing and e-tailing workshops was also held, at which industry experts imparted strategies for AI integration, cross-border market navigation, and brand influence elevation, arming participating brands with actionable intelligence. The organiser curated multiple networking events and arranged more than 170 one-on-one business matchmaking sessions for attendees and exhibitors. In addition, singer James Ng graced the event with a live performance during the conferences’ Happy Hour session.

Widespread industry support drives sector advancement

This year’s MarketingPulse and eTailingPulse received robust support from numerous organisations and industry bodies, including the Association of Accredited Advertising Agencies of Hong Kong (HK4As), the Hong Kong Internet & Ecommerce Association, the Hong Kong Federation of E-Commerce (HKFEC), the Hong Kong Live E-Commerce Association, the Hong Kong Public Relations Professionals’ Association, IAB Hong Kong and PRHK, providing attendees with invaluable market intelligence and unique perspectives.

Forum highlights available via Video on Demand for one month

The Video on Demand pass for MarketingPulse and eTailingPulse is available from today, 20 March, until 19 April. Industry professionals are encouraged to leverage the platform’s versatile features during this period to revisit the wealth of insights shared across the events.

Related websites

Photo download: https://bit.ly/4sVaOAg

HKTDC Executive Director Sophia Chong delivered the welcome remarks. She said the theme for this year’s events, "Generate New Growth", challenged us to seize these opportunities by exploring how fresh ideas, new technologies and bold strategies can power the next wave of momentum
HKTDC Executive Director Sophia Chong delivered the welcome remarks. She said the theme for this year’s events, “Generate New Growth”, challenged us to seize these opportunities by exploring how fresh ideas, new technologies and bold strategies can power the next wave of momentum

HKTDC Newsroom: http://mediaroom.hktdc.com/en

About HKTDC

The Hong Kong Trade Development Council (HKTDC) is a statutory body established in 1966 to promote, assist and develop Hong Kong’s trade. With over 50 offices globally, including 13 in Mainland China, the HKTDC promotes Hong Kong as a two-way global investment and business hub. The HKTDC organises international exhibitions, conferences and business missions to create business opportunities for companies, particularly small and medium-sized enterprises (SMEs), in the mainland and international markets. The HKTDC also provides up-to-date market insights and product information via research reports and digital news channels. For more information, please visit: www.hktdc.com/aboutus. Follow us on @hktdc and LinkedIn

PR Newswire is the official news release distribution partner of MarketingPulse and eTailingPulse.

KuCoin Institutional Introduces Quarterly VIP Level Shield to Strengthen Stability for VIP Traders

PROVIDENCIALES, Turks and Caicos Islands, March 20, 2026 /PRNewswire/ — KuCoin Insititutional today announced the launch of the Quarterly VIP Level Shield, a new structural loyalty mechanism designed to provide greater stability and protection for the platform’s high-tier traders and institutional clients.

The initiative introduces a quarterly protection framework for VIP5 and above users, ensuring that short-term market volatility or temporary changes in trading activity do not immediately trigger significant VIP tier downgrades. Instead, KuCoin implements a gradual and deferred adjustment mechanism, allowing loyal traders to maintain key benefits while navigating market cycles.

The new mechanism reflects KuCoin’s broader strategy to protect performance, stabilize loyalty, and retain VIP traders in an increasingly competitive exchange environment.

Supporting Long-Term Traders Through Market Cycles

Unlike short-term promotional campaigns, the Quarterly VIP Level Shield is designed as a structural enhancement to KuCoin’s VIP ecosystem. It recognizes users who have previously demonstrated meaningful trading activity or asset commitment, providing them with additional flexibility during periods of market fluctuation.

Through this mechanism, VIP users will no longer experience immediate multi-tier downgrades if their trading activity temporarily falls below VIP requirements. Instead, KuCoin will apply a controlled downgrade pace of no more than one level every 30 days, alongside quarterly minimum protection levels that safeguard core VIP privileges during the quarter.

A More Stable VIP Framework for Professional Traders

The Quarterly VIP Level Shield is designed to support high-frequency traders, institutional participants, and high-AUM clients, who are often sensitive to abrupt fee structure changes or sudden privilege adjustments. By reducing volatility in VIP level adjustments, the mechanism helps provide more predictable trading conditions and a more stable fee structure for long-term traders.

“Professional traders and institutions value stability and predictability in their trading environment,” said Tika Lum, Head of Global Business Development at KuCoin. “The Quarterly VIP Level Shield reflects our commitment to supporting long-term traders on KuCoin by providing a more flexible VIP framework — one that better supports ongoing participation, recognizes sustained engagement, and helps users navigate changing market conditions with greater confidence.”

KuCoin expects the initiative to further strengthen VIP loyalty, stabilize trading activity among top-tier clients, and reinforce the platform’s competitiveness in the global exchange landscape.

Strengthening the KuCoin VIP Ecosystem

As digital asset markets continue to evolve, KuCoin remains focused on building a client-centric institutional infrastructure that rewards loyalty, supports long-term participation, and enhances trading stability. The Quarterly VIP Level Shield represents another step toward creating a more resilient and trader-friendly ecosystem for professional market participants worldwide.

Please find the full details of the Quarterly VIP Level Shield.

About KuCoin Institutional

KuCoin Institutional is the institutional division of KuCoin, dedicated to providing professional investors, funds, and enterprises with secure, compliant, and efficient digital asset solutions. Integrating advanced trading infrastructure, capital management, and custody services, it offers a full-spectrum institutional ecosystem spanning liquidity access, risk control, and global compliance – empowering institutions to participate in the digital economy with confidence and transparency.

Learn more: www.kucoin.com